Online edition of India's National Newspaper
Thursday, Jan 03, 2008
ePaper
Google

Business
News: ePaper | Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous | Engagements |
Advts: Retail Plus | Classifieds | Jobs | Obituary |

Business - Briefly Printer Friendly Page   Send this Article to a Friend

Ranbaxy to market cetirizine in U.S.

GURGAON: Ranbaxy Laboratories has received the final approval from the U.S. Food and Drug Administration to manufacture and market cetirizine hydrochloride tablets (OTC) 5 mg and 10 mg. According to a release, this OTC product formulation further expands the portfolio of affordable generic alternatives and will be launched immediately to all classes of trade. — Corporate Reporter

Printer friendly page  
Send this article to Friends by E-Mail

Business

News: ePaper | Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous | Engagements |
Advts: Retail Plus | Classifieds | Jobs | Obituary | Updates: Breaking News |


News Update

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | Publications | eBooks | Images | Home |

Copyright © 2008, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu